Description

Artificial intelligence is revolutionizing the world in many ways. One of the most exciting applications of artificial intelligence is in the area of drug discovery. Particularly the discovery of antimicrobial molecules that are in the environment or even hidden within our own body. Today, we discuss some of the uses of artificial intelligence in the discovery of antimicrobials with an outstanding expert in the field.

Topics discussed:

• How artificial intelligence can help the discovery of new antimicrobial moieties
• Antibiotic discovery and challenges to bring molecules to the clinic
• The implications for artificial intelligence and infectious diseases in particularly in the discovery of antibiotics.

Guest:

• César de la Fuente, Ph.D., FRSB, Presidential Associate Professor at the University of Pennsylvania. Director, Machine Biology Group.

This episode is brought to you by the Antimicrobial Agents and Chemotherapy journal available at https://asm.org/aac. 

If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit https://asm.org/joinasm to sign up.

Visit https://asm.org/aac to browse issues and/or submit a manuscript.

Follow Cesar on twitter at https://twitter.com/SuperBugDoc for AAC updates. 

Get the audio only podcast at https://asm.org/eic.